Home » Topics » Regulatory » Patents

Patents
RSS

FORMA Therapeutics discloses mutant IDH1 inhibitors

Nov. 9, 2016

Sentinel Oncology patents p70S6K inhibitors

Nov. 9, 2016

Guangdong Zhongsheng Pharmaceutical describes thromboxane synthase inhibitors

Nov. 8, 2016

Guangzhou Maxinovel Pharmaceuticals develops ALK tyrosine kinase receptor inhibitors

Nov. 8, 2016

H. Lundbeck patents PDE1 inhibitors

Nov. 8, 2016

University of British Columbia develops ERalpha antagonists

Nov. 7, 2016

Genentech and Roche describe NMDA receptor modulators

Nov. 7, 2016

Jiangsu Hengrui Medicine discloses IDO1 and/or TDO inhibitors

Nov. 7, 2016

Ruijin Hospital, Brandeis University and Xiamen University patent protein kinase inhibitors

Nov. 7, 2016

Merck KGaA presents novel activin receptor-like kinase inhibitors

Nov. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.